AbbVie (ABBV)
(Delayed Data from NYSE)
$161.59 USD
+0.31 (0.19%)
Updated May 14, 2024 04:00 PM ET
After-Market: $161.46 -0.13 (-0.08%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
AbbVie Inc. [ABBV]
Reports for Purchase
Showing records 141 - 160 ( 376 total )
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for ABBV.
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for ABBV.
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended January 21.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for ABBV.
Provider: Stock Traders Daily
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended December 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended November 19
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 29.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 22.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended October 15.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 17
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AbbVie Inc.
Industry: Large Cap Pharmaceuticals
Provider: Zacks Investment Research
Analyst: Research Department